Leap Therapeutics
LPTX
LPTX
61 hedge funds and large institutions have $14.9M invested in Leap Therapeutics in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 18 closing their positions.
Holders
61
Holders Change
-11
Holders Change %
-15.28%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
15
Reduced
16
Closed
18
Calls
$43K
Puts
$4K
Net Calls
+$39K
Net Calls Change
-$189K
Top Buyers
1 |
ECM
1
Element Capital Management
New York
|
$521K |
2 |
2
Millennium Management
New York
|
$498K |
3 |
3
Renaissance Technologies
New York
|
$417K |
4 |
6CM
4
683 Capital Management
New York
|
$1.24M |
5 |
BC
5
BIT Capital
Berlin,
Germany
|
$165K |